![]() |
|
|
Vol. 281, Issue 1, 558-565, 1997
Department of Pharmacology, Texas Tech University Health Sciences
Center, Lubbock, Texas (J.D.M., P.J.S.), and
Division of Neurobiology,
Department of Neurology and Neuroscience, Cornell University Medical
College, New York, New York (D.L.F.)
Exposure to lipopolysaccharide (LPS) combined with
phorbol-12-myristate-13-acetate (PMA) stimulates de novo
synthesis of inducible nitric oxide synthase (NOS-2) in C6 glioma
cells. Ethanol dose-dependently inhibits C6 cell NOS-2 activity, as
measured by nitrite accumulation in culture medium, when present during
LPS plus PMA treatment. The present study reports on mechanisms related
to this inhibition. Ethanol added directly to cytosolic extracts did
not inhibit NOS-2 catalytic activity, nor did ethanol decrease nitrite
accumulation when added to cultures 24 hr after LPS plus PMA treatment.
In contrast, NOS-2 enzymatic activity was significantly decreased in
cytosolic extracts from cultures simultaneously exposed to ethanol and
LPS plus PMA for 24 hr. Immunoblot analysis showed a coincident
decrease in NOS-2 protein immunoreactivity. RNA analysis revealed that
NOS-2 mRNA was decreased at both 12 and 24 hr during LPS plus PMA
induction in the presence of ethanol. Subsequent experiments confirmed
that 12-hr exposure to ethanol was sufficient to inhibit
LPS/PMA-induced NOS-2 activity. Ethanol exposure also inhibited NOS-2
activity induced by LPS plus interferon-
, by LPS plus tumor necrosis
factor-
and by tumor necrosis factor-
alone. These data point to
an inhibitory ethanol effect at a site downstream from cytokine
receptor activation and second messenger signal transduction mechanisms
leading to suppression of NOS-2 gene expression in C6 cells.